Table 2.
Urogenital Distress Inventory (UDI-6) scores: women with PVRV <150 mL compared with women with PVRV ≥150 mL
Day 0 | Day 4 | Day 7 | Day 30 | Day 90 | Day 365 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
< 150 mL | ≥ 150 mL | p value | < 150 mL | ≥ 150 mL | p value | < 150 mL | ≥ 150 mL | p value | < 150 mL | ≥ 150 mL | p value | < 150 mL | ≥ 150 mL | p value | < 150 mL | ≥ 150 mL | p value | |
n = 94 | n = 119 | n = 72 | n = 100 | n = 69 | n = 77 | n = 63 | n = 68 | n = 57 | n = 64 | n = 63 | n = 80 | |||||||
UDI-6 total scorea | 10.8 ± 14.5 | 11.4 ± 12.6 | 0.4 | 9 ± 11.2 | 8.6 ± 10.2 | 0.6 | 7.5 ± 7.6 | 9.4 ± 13.6 | 0.9 | 6.6 ± 9.2 | 6.1 ± 9.5 | 0.6 | 5.8 ± 8.7 | 8.0 ± 10.6 | 0.2 | 8.1 ± 11.1 | 9.8 ± 11.3 | 0.2 |
Irritative symptomsa | 9.6 ± 18.7 | 13.6 ± 17.4 | 0.015 | 5.8 ± 11.2 | 7.5 ± 13.9 | 0.6 | 5.6 ± 10.9 | 7.6 ± 17.2 | 0.9 | 6.1 ± 11.8 | 3.9 ± 9.6 | 0.2 | 3.5 ± 8.2 | 6.3 ± 12.0 | 0.3 | 7.7 ± 14.3 | 10.4 ± 17.5 | 0.2 |
Stress symptomsa | 11.5 ± 18 | 9.0 ± 15.6 | 0.2 | 7.2 ± 14.5 | 5.5 ± 10.9 | 0.8 | 12.6 ± 15.8 | 8.0 ± 17.0 | 0.6 | 7.4 ± 12.9 | 7.1 ± 13.6 | 0.7 | 8.8 ± 14.8 | 10.1 ± 16.4 | 0.6 | 10.6 ± 16.7 | 10.6 ± 17.0 | 0.8 |
Obstructive symptomsa | 11.5 ± 20 | 11.8 ± 17.5 | 0.4 | 13.9 ± 18.5 | 12.7 ± 17.4 | 0.7 | 6.6 ± 9.2 | 12.6 ± 16.3 | 0.8 | 6.4 ± 11.4 | 7.1 ± 12.9 | 0.8 | 5.0 ± 9.9 | 7.6 ± 11.8 | 0.2 | 6.1 ± 12.8 | 8.5 ± 15.2 | 0.2 |
aMean ± SD)